TechnoPhage owns an innovative unit for the production of biological medicines that has now obtained authorization from INFARMED for the manufacture and analysis of medicines, becoming one of the few in the country with this capacity.

The unit established in Venda Nova (Amadora) will manufacture, at this stage, biological medicines for use in clinical trials. The new structure consists of a production area and a quality control unit where the tests that support all production activities are carried out. State-of-the-art equipment and highly qualified personnel, with several years of experience in the biopharmaceutical and pharmaceutical industry, ensure the proper functioning of said unit, and uphold the INFARMED certification for production according to Good Manufacturing Practices (GMP).

For Miguel Garcia, CEO of TechnoPhage, “This innovative unit for the production of biological medicines in a GMP environment appears as the ideal solution, providing TechnoPhage with the possibility of producing its own products and offering a quality service to other national and international companies. TechnoPhage intends, with these new facilities and capabilities, to show its pioneering potential which is simultaneously 100% Portuguese.”